OptimizeRx (OPRX) Other Non Operating Income (2019 - 2026)

OptimizeRx (OPRX) has 8 years of Other Non Operating Income data on file, last reported at $38000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income fell 2.56% year-over-year to $38000.0; the trailing twelve-month figure through Mar 2026 stood at $196000.0 (up 2.62% YoY), and the FY2025 full-year result was $198000.0, up 30.26% from the prior year.
• Other Non Operating Income fell to $38000.0 in Q1 2026, from $59000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $720419.0 in Q2 2023 to a low of -$1.6 million in Q4 2023.
• A 5-year average of $108706.1 and a median of $49000.0 in 2024 frame the typical range for Other Non Operating Income.
• Peak annual rise in Other Non Operating Income reached 22182300.0% in 2023, while the deepest fall reached 392.3% in 2023.
• Tracing OPRX's Other Non Operating Income over 5 years: stood at $538512.0 in 2022, then sank by 392.3% to -$1.6 million in 2023, then surged by 102.48% to $39000.0 in 2024, then jumped by 51.28% to $59000.0 in 2025, then slumped by 35.59% to $38000.0 in 2026.
• Business Quant data shows OPRX's Other Non Operating Income at $38000.0 in Q1 2026, $59000.0 in Q4 2025, and $62000.0 in Q3 2025.